Evidence for the Efficacy of a Bioresonance Method in Smoking Cessation: A Pilot Study

Background: Since the 1970s, MORA bioresonance therapy has globally been applied in the context of complementary medicine for various indications. In this regard, practitioners also report successful application in smoking cessation. The present study aims to verify these reports in a controlled study setting. Methods: In order to achieve the aforementioned objective, we subjected the bioresonance method to a prospective, placebo-controlled, double-blind, parallel-group study involving 190 smokers. In both study groups (placebo n = 95; active bioresonance group; n = 95) the course of treatment and study conditions were standardized. Results: 1 week (77.2% vs. 54.8%), 2 weeks (62.4% vs. 34.4%), 1 month (51.1% vs. 28.6%), and 1 year (28.6% vs. 16.1%) after treatment, the success rate in the verum group differed significantly from the results in the placebo group. Also, the subjective health condition after treatment and subjective assessment of efficacy, polled after 1 week, were significantly more positive among participants in the active bioresonance therapy group than among those in the placebo group. Adverse side effects were not observed. Conclusion: According to the findings attained by this pilot study, bioresonance therapy is clinically effective in smoking cessation and does not show any adverse side effects.

[1]  C. Xue,et al.  Ear Acupressure for Smoking Cessation: Study Protocol for a Randomised Controlled Trial , 2013, Complementary Medicine Research.

[2]  M. Tsai,et al.  Effectiveness of MORA electronic homeopathic copies of remedies for allergic rhinitis: A short-term, randomized, placebo-controlled PILOT study , 2013 .

[3]  B. Riegel.  Hypnosis For Smoking Cessation: Group and Individual Treatment—A Free Choice Study , 2013, The International journal of clinical and experimental hypnosis.

[4]  J. S. Castillo,et al.  Terapias alternativas para la cesación de la adicción al tabaco: revisión de guías de práctica clínica , 2012 .

[5]  Kenneth W Lin,et al.  Nicotine receptor partial agonists for smoking cessation. , 2011, American family physician.

[6]  M. Galle,et al.  Retrospective surgery study of the therapeutic effectiveness of MORA bioresonance therapy with conventional therapy resistant patients suffering from allergies, pain and infection diseases , 2010 .

[7]  L. Stead,et al.  Hypnotherapy for smoking cessation. , 2010, The Cochrane database of systematic reviews.

[8]  L. Montagnier,et al.  Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences , 2009, Interdisciplinary Sciences Computational Life Sciences.

[9]  G. Mikhailova,et al.  Effect of exogenous frequency exposure on human cells , 2008, Bulletin of experimental biology and medicine.

[10]  V. Rahlfs,et al.  Wirksamkeit und Verträglichkeit der Bioresonanzbehandlung , 2008 .

[11]  J. O'Loughlin,et al.  Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials , 2008, Canadian Medical Association Journal.

[12]  M. Galle,et al.  Untersuchung zur klinischen Wirksamkeit elektronisch abgespeicherter Zahn- und Gelenksnosoden bei Erkrankungen des rheumatischen Formenkreises , 2007, Complementary Medicine Research.

[13]  V. Korenbaum,et al.  Absorption Spectra of Electronic-Homoeopathic Copies of Homoeopathic Nosodes and Placebo Have Essential Differences , 2006, Complementary Medicine Research.

[14]  S. Tonstad,et al.  Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[15]  Jason Gong,et al.  Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial , 2006 .

[16]  David Gonzales,et al.  Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial , 2006 .

[17]  W. Pichler,et al.  Bioresonanz — diagnostischer und therapeutischer Unsinn , 2006, Aktuelle Dermatologie.

[18]  M. Galle,et al.  Plazebokontrollierte Studie zur Wirkung einer standardisierten MORA-Bioresonanztherapie auf funktionelle Magen-Darm-Beschwerden , 2006, Complementary Medicine Research.

[19]  A. Steciwko,et al.  Low-frequency electromagnetic stimulation may lead to regression of Morris hepatoma in buffalo rats. , 2004, Journal of alternative and complementary medicine.

[20]  T. Coleman.  Acupuncture in smoking cessation. , 1998, The British journal of general practice : the journal of the Royal College of General Practitioners.

[21]  M. Schöni,et al.  Efficacy trial of bioresonance in children with atopic dermatitis. , 1997, International archives of allergy and immunology.

[22]  J. Schulte,et al.  Non-molecular information transfer from thyroxine to frogs with regard to homeopathic toxicology. , 1995, Veterinary and human toxicology.

[23]  Karl Fagerstrom,et al.  Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire , 1989, Journal of Behavioral Medicine.

[24]  R. Carney,et al.  The Efficacy of Auriculotherapy for Smoking Cessation: A Randomized, Placebo-Controlled Trial , 2013, The Journal of the American Board of Family Medicine.

[25]  R. Murillo,et al.  [Alternative therapies for smoking cessation: clinical practice guidelines review]. , 2012, Gaceta Médica de México.

[26]  L. Stead,et al.  Nicotine receptor partial agonists for smoking cessation (Review) , 2007 .

[27]  S. Rennard,et al.  Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[28]  N. Rigotti,et al.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. , 2006, JAMA.

[29]  L. Stead,et al.  Acupuncture and related interventions for smoking cessation. , 2006, The Cochrane database of systematic reviews.

[30]  Gogoleva Ef.  New approaches to diagnosis and treatment of fibromyalgia in spinal osteochondrosis , 2001 .

[31]  J. Benveniste,et al.  Activation of human neutrophils by electronically transmitted phorbol-myristate acetate. , 2000, Medical hypotheses.

[32]  Gogoleva Ef,et al.  Outpatient bioresonance treatment of gonarthrosis , 2000 .

[33]  L. Stead,et al.  Hypnotherapy for smoking cessation. , 2000, The Cochrane database of systematic reviews.